Table 2.
Participant Demographic, Adherence, and Disease Characteristics
Adolescent age (years) | 15.4 ± 1.5 | |
Gender (% male) | 50% | |
Ethnicity (% White, not Hispanic origin) | 90% | |
Primary Caregiver: | ||
Age (years) | 46.2 ± 4.9 | |
Marital Status (% married) | 87.5% | |
Education Level (% with at least a college degree) | 45% | |
Annual Household Income (Median) | $100,001-125,000 | |
IBD Diagnosis (%): | ||
Crohn's Disease | 75.0% | |
Ulcerative Colitis | 17.5% | |
Indeterminate Colitis | 7.5% | |
Disease Severity: | Baseline | Post-treatment |
PHBI | 2.10 ± 2.27 | 2.87 ± 2.66 |
PUCAI | 14.0 ± 15.06 | 12.0 ± 14.18 |
Adherence: | ||
Pill Count - 6-MP/azathioprine | 66% | 56% |
Pill Count - mesalamine | 51% | 50% |
Electronic monitor | 89% | 84% |
Parent-reported - 6-MP/azathioprine | 83% | 81% |
Parent-reported - mesalamine | 89% | 94% |
Teen-reported - 6-MP/azathioprine | 87% | 87% |
Teen-reported - mesalamine | 93% | 96% |